Company / FCF Margin
Ginkgo Bioworks Holdings, Inc. FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-105.0%
FY2025
5-year range
-168.3% / -63.7%
FY2021-FY2025
Trend
+37.6%
vs FY2024
Sector context
#89 of 131
Health Care
What the data says
At -105.0%, Ginkgo Bioworks Holdings, Inc.'s fcf margin ranks #89 of 131 in the Health Care sector. FCF Margin returned to growth in FY2025 after 2 years of decline, reaching -105.0%.
Based on SEC 10-K filings.
-105.0% in FY2025 with a 3-year CAGR of -41.3%.
Improved from -133.7% to -105.0% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -41.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#89 of 131 in Health CareTop 68% of 131This company -105.0% Sector average -646.9%
▼
+83.8% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 37.6% year-over-year.
- Currently 541.9pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -105.0% | +37.6% |
| FY2024 | -168.3% | -25.8% |
| FY2023 | -133.7% | -109.8% |
| FY2022 | -63.7% | +35.5% |
| FY2021 | -98.9% | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026